The most important is that we continue to promote a science-based regulatory system through all our interventions—whether it's bilaterally, multilaterally, or through trade agreements—and the ability to further define that in areas where we see opportunity for a lot more risk in the future, the areas we've talked about today. A recommendation from the committee to be able to articulate that as a priority would be very helpful.
On February 23rd, 2017. See this statement in context.